View PDF VersionPrevious ArticleNext Article

Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence
DOI: 10.1039/D5RA06806A (Review Article) RSC Adv., 2025, 15, 47383-47398

Comprehensive review of Bletilla striata polysaccharides: from fundamental studies to innovative biomaterials

Jinxiang Fu† a, Yi Lu†b, Wennuo Xua, Kangdi Hua, Ting Caoa, Ronghua Fan*ac and Song Cang*a
aDepartment of Sanitary Inspection, School of Public Health, Shenyang Medical College, No. 146, North Huanghe Street, Shenyang 110034, Liaoning province, China. E-mail: cangsong517@163.com; ronghuafan1@126.com
bSecond Affiliated Hospital of Shenyang Medical College, Shenyang 110032, China
cShenyang Key Laboratory of Chronic Disease Assessment and Nutritional Intervention for Heart and Brain, Shenyang Medical College, Shenyang 110034, China

Received 9th September 2025 , Accepted 19th November 2025

First published on 2nd December 2025

Abstract

Bletilla striata (Thunb.) Rchb.f. is a perennial medicinal orchid with a well-documented history in traditional Chinese medicine spanning millennia. Clinically employed for treating mucosal injuries, ulcers, trauma, and burns, this botanical exhibits diverse pharmacological properties attributed to its rich composition of bioactive compounds. Among these constituents, Bletilla striata polysaccharides have emerged as the primary pharmacologically active components, demonstrating remarkable anti-inflammatory activity, wound healing, hemostatic activity, antioxidant activity, and antimicrobial activity. When compounded with macromolecular components to create emerging hydrogels, sponges, microneedles, eye drops and films, the resulting materials surpass traditional products in mechanical performance, biocompatibility and biodegradability, offering an ideal platform for wound management, tissue repair and regenerative medicine. Future clinical translation of BSPs will be advanced by optimizing scalable production and systematically evaluating the clinical safety of its biomaterials. In this paper, the research progress of extraction and purification, chemical structure characterization, biological activity of BSPs and new BSP-based composite biomaterials that harness the biological activity of BSP in recent years were reviewed. This paper will promote the understanding of BSP and provide a theoretical basis for the development of new biological materials.

1. Introduction

The genus Bletilla Rchb.f. (Orchidaceae) represents a group of perennial herbaceous plants comprising approximately six recognized species, predominantly distributed across East Asia, including northern Myanmar, China, South Korea, and Japan.1 Within the Chinese territory, four distinct species have been identified and characterized: B. formosana (Hayata) Schltr., B. ochracea Schltr., B. sinensis (Rolfe) Schltr., and B. striata (Thunb.) Rchb.f. (Fig. 1 and Table 1).2 Among these species, Bletilla striata has emerged as the most pharmacologically significant, characterized by its robust erect stems (12–60 cm in height), 4–6 lanceolate leaves, and distinctive purple to lavender inflorescences, giving it both ornamental and medicinal value.
image file: d5ra06806a-f1.tif
Fig. 1 (A) Four kinds of Bletilla floweSrs: Bletilla formosana (a), Bletilla ochracea (b), Bletilla sinensis (c), Bletilla striata (d) (B) Bletilla tubers (e). (pictures from ‘Flora of China’ and WeChat public number: Changyang Hospital of Traditional Chinese Medicine).
Table 1 Distribution of Bletilla Rchb.f
Latin name Chinese name Distribution
Bletilla formosana “Xiao Bai Ji” image file: d5ra06806a-u1.tif China
Bletilla ochracea “Huang Hua Bai Ji” image file: d5ra06806a-u2.tif China
Bletilla sinensis “Hua Bai Ji” image file: d5ra06806a-u3.tif China
Bletilla striata “Bai Ji” image file: d5ra06806a-u4.tif China, Japan, South Korea
Bletilla guizhouensis “Gui Zhou Bai Ji” image file: d5ra06806a-u5.tif China
Bletilla chartacea “Mian Dian Bai Ji” image file: d5ra06806a-u6.tif Northern Myanmar

Traditional Chinese Medicine (TCM) classifies B. striata as a herb with a bitter taste, neutral thermal nature, and non-toxic properties. Its therapeutic applications have been well-documented in classical medical texts for the treatment of various conditions, including but not limited to epistaxis, hematemesis, pulmonary injuries, gastrointestinal hemorrhage, and dermatological disorders.3 Contemporary pharmacological studies have substantiated these traditional uses through the identification of multiple bioactive properties, including immunomodulatory,4 antioxidant effects,5 anti-inflammatory effects,6 antibacterial effects,7 hemostatic,8 anti-influenza virus,9 anti-cancer10 and other activities.11,12

The tuberous roots of B. striata constitute the primary medicinal component, containing a complex array of bioactive compounds. Recent phytochemical investigations have identified hundreds of constituents, including polysaccharides (approximately 30% of dry weight),13 phenanthrenes and their derivatives, dihydrophenanthrenes, and biphenyl compounds.14 Among these, Bletilla polysaccharides (BSPs) have garnered particular attention due to their demonstrated pharmacological efficacy, particularly in anti-inflammatory, antioxidant, antimicrobial, and hemostatic applications.14 The structural complexity and biological activities of BSPs have positioned them as promising candidates for the development of novel therapeutic agents and biomaterials.

The burgeoning interest in plant-derived polysaccharides as innovative biomaterials has gained substantial momentum in recent years, driven by their biocompatibility, biodegradability, and versatile biological activities.15,16 While numerous studies have extensively documented the pharmacological profile of BSPs,17,18 the exploration of their potential as functional biomaterials remains relatively unexplored. This paper aims to review the application potential of its biomaterials in biomedicine based on the biological activity of BSP, and summarize the extraction process and structural characteristics of BSP, so as to provide reference for further development of BSP biomaterials and promote the application and development of BSP in the future.

2. Structural characteristics of polysaccharides from Bletilla striata

The chemical structure of polysaccharides is often closely related to their biological activity and pharmacological effects. It is necessary to study and describe the biological activity of polysaccharides and understand their structural characteristics. At present, more and more biological activities of Bletilla striata polysaccharide have been found, and its structural characteristics have also been paid attention to by many scholars. The main structural characteristics include its molecular weight, monosaccharide composition, chemical structure and glycosidic bond position. Common structural characterization methods include high performance gel permeation chromatography, high performance liquid chromatography, infrared spectroscopy, nuclear magnetic resonance, gas chromatography and mass spectrometry or a combination of the two, Fourier transform infrared spectroscopy, methylation analysis, acid hydrolysis and other analytical methods.

2.1. Molecular weight

The molecular weight distribution of BSPs is typically characterized using two primary parameters: number-average molecular weight (Mn) and weight-average molecular weight (Mw), with Mw being more commonly reported due to its greater relevance to solution properties and biological activities. Size-dependent separation techniques, particularly high-performance gel permeation chromatography (HPGPC),19 have emerged as the gold standard for molecular weight determination of BSPs. HPGPC operates on the principle of size exclusion chromatography (SEC), where polysaccharide molecules are separated based on their hydrodynamic volume through porous stationary phases with defined pore size distributions. This technique offers several advantages, including non-destructive analysis, high reproducibility, and compatibility with various detection systems such as refractive index (RI) and multi-angle laser light scattering (MALLS) detectors.

The molecular weight profile of BSPs exhibits significant variation depending on extraction methodologies. Comparative studies have demonstrated that conventional hot water extraction typically yields BSPs with higher molecular weights (282.91–402.17 kDa),5 while alkaline extraction and ultrasonic-assisted methods tend to produce lower molecular weight fractions (195.83–230.63 kDa).5,20 Recent investigations have further elucidated this molecular weight diversity, with reported values ranging from 10 kDa to 500 kDa across different extraction protocols and purification fractions (Table 2). Specifically, alkaline-extracted BSP fractions have shown a broad molecular weight distribution (28.153–269.121 kDa),19 while hot water-extracted BSPs generally maintain higher molecular weights (229–255.172 kDa).21,22 Notably, gel permeation chromatography (GPC) analyses have identified low molecular weight BSP fractions (28[thin space (1/6-em)]365 Da),23 suggesting the presence of oligosaccharide components in certain preparations.

Table 2 Structural characteristics and extraction methods of Bletilla striata polysaccharides
Name Monosaccharide composition (% molar ratio) Molecular weight (Mw) Structural characteristics Extraction method Ref.
BSPb Glu[thin space (1/6-em)]:[thin space (1/6-em)]Man = 1[thin space (1/6-em)]:[thin space (1/6-em)]3 2.60 × 105 Da The main chain formed by (1 → 2) and (1 → 4) glycosidic bonds Hot water extraction 27
pFSP D-Glu[thin space (1/6-em)]:[thin space (1/6-em)]D-Man[thin space (1/6-em)]:[thin space (1/6-em)]D-Galactose = 1[thin space (1/6-em)]:[thin space (1/6-em)]2.03[thin space (1/6-em)]:[thin space (1/6-em)]3.45 9.10 × 104 Da The main chains of (1 → 4) -connected α-D-Glcp, (1 → 4) -connected β-D-Manp and (1 → 3, 6) -connected β-D-Manp units Hot water extraction 24
BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc = 2.4[thin space (1/6-em)]:[thin space (1/6-em)]1.0 1.35 × 105 Da Backbone composed of 1,4-linked manp Hot water extraction 28
BSP-1 Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu = 4[thin space (1/6-em)]:[thin space (1/6-em)]1 8.35 × 104 Da The main chain is composed of β-1,4-D-mannose and β-1,4-D-glucose Hot water extraction 40
BSP-2 Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu = 3[thin space (1/6-em)]:[thin space (1/6-em)]1 1.26 × 104 Da The main chain is composed of β-1,4-D-mannose and β-1,4-D-glucose Hot water extraction 40
BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu = 2.946[thin space (1/6-em)]:[thin space (1/6-em)]1 3.73 × 105 Da A branched polysaccharide composed of (1 → 4)-β-D-mannopyranose in the main chain Hot water extraction 41
BSPF2 Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu[thin space (1/6-em)]:[thin space (1/6-em)]Galactose = 9.4[thin space (1/6-em)]:[thin space (1/6-em)]2.6[thin space (1/6-em)]:[thin space (1/6-em)]1.0 2.35 × 105 Da The main chain is composed of (1 → 4) -mannose and (1 → 4) -glucose Hot water extraction 25
BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc = 7.45[thin space (1/6-em)]:[thin space (1/6-em)]2.55 1.70 × 105 Da — Hot water extraction 42
BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu = 2.9[thin space (1/6-em)]:[thin space (1/6-em)]1 2.80 × 104 Da The main chain is (→6) -β-Manp- (1→, →4) -β-Glcp- (1→, →4) -β-Manp (1 →, →3) -α-Manp- (1→), β-Glcp- (1→ and β-Manp- (1→)) Hot water extraction 23
BSAP Glu[thin space (1/6-em)]:[thin space (1/6-em)]Xylose[thin space (1/6-em)]:[thin space (1/6-em)]Man = 2.39[thin space (1/6-em)]:[thin space (1/6-em)]1.00[thin space (1/6-em)]:[thin space (1/6-em)]0.21 2.29 × 105 Da — Hot water extraction 21
BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu = 2.4[thin space (1/6-em)]:[thin space (1/6-em)]1 1.46 × 105 Da — — 43
BSP-1 Galactose[thin space (1/6-em)]:[thin space (1/6-em)]Glu[thin space (1/6-em)]:[thin space (1/6-em)]Man = 0.53[thin space (1/6-em)]:[thin space (1/6-em)]24.91[thin space (1/6-em)]:[thin space (1/6-em)]74.56 2.69 × 105 Da The main chain is composed of α-D-Glcp, β-D-Glcp, β-D-Manp and 2-O-acetyl-β-D-Manp Alkali water extraction 20
BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc = 3.5[thin space (1/6-em)]:[thin space (1/6-em)]1.0 2.00 × 104 Da Backbone composed of (1 → 4)-linked β-D-glucopyranosyl residues and (1 → 4)-linked β-D-mannopyranosyl residues Ultrasonic-assisted extraction 44
LMW-BSP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glu = 1.26[thin space (1/6-em)]:[thin space (1/6-em)]1 2.30 × 104 Da The main chain is composed of α-D-manp-(1 → 3)-β-D-manp-(1 → 4)-β-D-Glcp-(1,2 → 4)-β-D-manp-(1 → 3)-β-D-manp-(1→) Water extraction 45
BVPS Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc = 7.37[thin space (1/6-em)]:[thin space (1/6-em)]2.63 1.47 × 105 Da — Hot water extraction 46
BFPS Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc = 7.4[thin space (1/6-em)]:[thin space (1/6-em)]2.6 9.55 × 104 Da — Hot water extraction 46
RBP Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc = 2[thin space (1/6-em)]:[thin space (1/6-em)]1 8.20 × 105 Da Backbone composed of β-1,4-linked D-mannosyl residues and β-1,4- linked D-glucosyl residues Hot water extraction 47

2.2. Monosaccharide composition

Polysaccharides are complex biopolymers composed of monosaccharide units linked through glycosidic bonds, which can be classified as either homopolysaccharides (consisting of a single type of monosaccharide) or heteropolysaccharides (comprising multiple monosaccharide types). Structural analyses have revealed that BSPs predominantly exist as heteropolysaccharides, with glucose (Glc), mannose (Man), and galactose (Gal) constituting the primary monosaccharide components, although homopolysaccharide fractions have also been identified.

The monosaccharide composition of BSPs is typically determined using advanced chromatographic techniques, with ion chromatography (IC) and gas chromatography (GC) being the most widely employed methods. These techniques provide precise quantification of monosaccharide constituents and their molar ratios. For instance, ion chromatographic analysis of hot water-extracted pFSP revealed a molar ratio of D-Glc[thin space (1/6-em)]:[thin space (1/6-em)]D-Gal[thin space (1/6-em)]:[thin space (1/6-em)]D-Man = 1.00[thin space (1/6-em)]:[thin space (1/6-em)]2.03[thin space (1/6-em)]:[thin space (1/6-em)]3.45, indicating a mannose-rich polysaccharide structure.24 Similarly, Liu et al.21 identified Glc, Xyl, and Man in BSAP with a molar ratio of 2.39[thin space (1/6-em)]:[thin space (1/6-em)]1.00[thin space (1/6-em)]:[thin space (1/6-em)]0.21, demonstrating the presence of xylose (Xyl) in certain BSP fractions. Gas chromatographic analysis of hot water-extracted BSPF2 further confirmed the heterogeneity of BSPs, showing a Man[thin space (1/6-em)]:[thin space (1/6-em)]Glc[thin space (1/6-em)]:[thin space (1/6-em)]Gal ratio of 9.4[thin space (1/6-em)]:[thin space (1/6-em)]2.6[thin space (1/6-em)]:[thin space (1/6-em)]1.0,25 which suggests significant structural variability among different BSP fractions.

2.3. Chemical structure and glycosidic bond

Structural elucidation studies have identified BSPs as glucomannans characterized by a backbone predominantly composed of (1 → 4)-linked β-D-mannopyranosyl and (1 → 4)-linked β-D-glucopyranosyl residues (Fig. 2). Advanced structural characterization techniques, including methylation analysis, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry-chromatography integration, have been instrumental in deciphering the complex architecture of BSPs.26
image file: d5ra06806a-f2.tif
Fig. 2 The possible structural features of BSPs. (A) the structure of BSP-A/B/H/U;5 (B) the structure of BSPF2;25 (C) the structure of BSP;23 (D) the structure of BSP;28 (E) the structure of pFSP;24 (F) the structure of BSPb.27

Comprehensive structural analyses have revealed significant heterogeneity in BSP configurations. Wang et al.27 demonstrated through methylation and NMR analysis that BSPb possesses a backbone structure primarily consisting of (1 → 2)-linked α-D-mannopyranose and (1 → 4)-linked β-D-glucopyranose residues. Further structural investigations by Chen et al.20 utilizing ion chromatography, gas chromatography-mass spectrometry (GC-MS), and NMR spectroscopy identified BSP-1 as containing α-D-Glcp, β-D-Glcp, β-D-Manp, and 2-O-acetyl-β-D-Manp residues, with branching units of β-D-Galp and α-D-Glcp.

Notably, Qiu et al.22 provided evidence of a triple-helical configuration in pBSP1 through Congo red binding assays, with NMR analysis revealing a glucose[thin space (1/6-em)]:[thin space (1/6-em)]mannose ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]2.95 and the presence of diverse glycosidic linkages, including (1 → 6), (1 → 2), and (1 → 4) bonds. Additional structural insights were provided by the identification of repeating units in hot water-extracted pFSP, which contained (1 → 4)-α-D-Glcp, (1 → 4)-β-D-Manp, and (1 → 3,6)-β-D-Manp units, with side chains terminated by (1 → )-β-D-Manp residues.24

3. Extraction and purification method of Bletilla striata polysaccharide

3.1. Extraction methods

The optimization of extraction protocols is crucial for obtaining BSPs with consistent structural integrity and biological activity. Current extraction techniques can be broadly classified into conventional methods and advanced assisted-extraction technologies, each with distinct advantages in terms of yield, purity, and preservation of structural features. Table 2 summarizes the structural characteristics and extraction methods of BSPs.
3.1.1. Hot water extraction methods. The hot water extraction method, based on the hydrophilic properties of polysaccharides, enhances extraction efficiency through optimization of key parameters including extraction temperature, duration, and solid–liquid ratio. As the most established technique for BSP isolation, this method has been extensively studied using statistical optimization approaches such as response surface methodology (RSM) and orthogonal experimental design. Chen et al.5 demonstrated that optimal extraction conditions (solid–liquid ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]30, extraction temperature of 70 °C, and duration of 3 hours) yielded a BSP extraction rate of 21.64%. While this traditional method offers advantages in terms of simplicity and scalability, it is associated with several limitations, including prolonged extraction times and significant energy consumption due to sustained heating requirements.
3.1.2. Alkaline water extractions. The alkaline water extraction method capitalizes on the enhanced solubility of polysaccharides under basic conditions, where partial cleavage of glycosidic bonds facilitates the release of polysaccharide components from the cellular matrix. This method shares the fundamental principle of water solubility with hot water extraction but operates through an additional mechanism of alkaline-induced structural modification.29 Optimization studies have demonstrated the effectiveness of this approach. Chen et al.5 achieved an extraction yield of 18.29% using 0.005 mol per L NaOH at 60 °C for 3 hours. Further optimization by subsequent researchers established that extraction at 52 °C for 167 minutes with 0.01 mol per L NaOH could increase the yield to 29.53%.30 While the alkaline extraction method generally provides higher extraction efficiency compared to conventional hot water extraction, it presents several limitations: (1) potential degradation of polysaccharide structure due to alkaline hydrolysis, (2) environmental concerns associated with alkali usage and waste disposal, and (3) possible alteration of bioactivity due to structural modifications.
3.1.3. Enzymatic hydrolysis methods. The enzymatic-assisted extraction method utilizes the catalytic activity of specific enzymes (e.g., pectinases, cellulases) to degrade plant cell wall components, thereby enhancing the release and recovery of polysaccharides. This approach is particularly effective for disrupting the structural integrity of plant cells while preserving the target compounds' bioactivity.31 Han et al.32 demonstrated the efficacy of cellulase in BSP extraction, achieving a yield of 28.72% under optimized conditions: cellulase dosage of 17[thin space (1/6-em)]600 U g−1, extraction temperature of 65 °C, and hydrolysis duration of 90 minutes. Further optimization by Sun et al.33 using papain revealed that the highest polysaccharide purity (92%) could be achieved under the following conditions: extraction time of 120–150 minutes, pH 7.0–7.5, temperature of 45–50 °C, and enzyme dosage of 8–10 mg g−1. Compared to traditional extraction methods, enzymatic-assisted extraction offers several advantages: (1) higher extraction efficiency, (2) reduced environmental impact due to lower energy consumption and chemical usage, and (3) improved preservation of polysaccharide structure and bioactivity. However, this method is subject to strict reaction conditions, including precise control of pH, temperature, and enzyme activity, which may limit its scalability and industrial application.
3.1.4. Ultrasonic extractions. The ultrasonic-assisted extraction method leverages the physical cavitation effect of ultrasound waves to disrupt plant cell walls, facilitating the release of intracellular polysaccharides and enhancing solvent penetration. This non-thermal extraction technique significantly improves mass transfer efficiency through mechanical and thermal effects generated by ultrasonic waves.34 Qiu et al.22 employed an integrated optimization approach combining orthogonal design, Box–Behnken design (BBD), and genetic algorithm-back propagation (GA-BP) neural network modeling to determine the optimal extraction conditions for BSP. The optimized parameters (liquid-to-material ratio of 15 mL g−1, ultrasonic power of 450 W, and extraction time of 34 minutes) yielded a polysaccharide extraction rate of 8.29%, with notable antioxidant activity (26.20 ± 0.28 mM FE per mg). In a separate study, Han et al.32 achieved a higher extraction yield (35.01%) for BSP-V under the following conditions: extraction time of 1 hour, ultrasonic power of 250 W, temperature of 30 °C, and liquid-to-solid ratio of 30 mL g−1. Compared to conventional extraction methods, ultrasonic-assisted extraction offers several advantages: (1) significantly reduced extraction time, (2) improved extraction efficiency, and (3) lower energy consumption. However, the method's efficacy is highly dependent on optimal parameter control, including ultrasonic power, frequency, and extraction duration.
3.1.5. Microwave extraction methods. The microwave-assisted extraction method operates through two primary mechanisms: (1) the thermal effect, which induces rapid heating of polar molecules, and (2) the non-thermal effect, which enhances mass transfer by disrupting hydrogen bonds and dipole rotations. This technique facilitates the rapid transfer of target compounds from the plant matrix to the solvent by generating localized increases in temperature and pressure, thereby improving extraction efficiency.35 Han et al.32 optimized the microwave extraction of BSP-M, achieving an extraction yield of 42.82% under the following conditions: pH 7.0, solid–liquid ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]30, microwave power of 600 W, and extraction time of 9 minutes. This method demonstrates significant advantages over traditional techniques, including (1) higher extraction efficiency, (2) reduced solvent consumption, (3) shorter processing times, and (4) lower energy requirements. However, its application is limited by the high cost of specialized equipment and challenges in scaling up for industrial production.
3.1.6. Infrared-assisted extraction methods. As an emerging extraction technology, infrared-assisted extraction has gained attention for its ability to efficiently isolate bioactive compounds from plant materials. The method operates on the principle of infrared radiation-induced thermal effects, which enhance molecular vibration and thermal motion of polysaccharides within plant cells, thereby improving their solubility and mass transfer rates.36 Qu et al.37 pioneered the application of this technique for Bletilla striata polysaccharide extraction. Using a Box–Behnken design combined with response surface methodology, they optimized the extraction parameters and achieved a crude polysaccharide yield of 43.95%. Compared to ultrasonic and microwave-assisted extraction methods, infrared-assisted extraction offers several distinct advantages: (1) operational simplicity, (2) reduced reliance on complex instrumentation, and (3) minimal risk of thermal degradation. However, the method is associated with higher energy consumption during prolonged extraction processes, which may limit its industrial scalability.
3.1.7. Deep eutectic solvents (DESs). Deep eutectic solvents (DESs) represent a novel class of green solvents characterized by their unique composition of hydrogen bond donors (HBDs) and hydrogen bond acceptors (HBAs) in specific molar ratios. These solvents exhibit remarkable properties, including low melting points, negligible volatility, and excellent solvation capabilities, making them particularly suitable for the extraction of bioactive compounds.38 In the extraction of Bletilla striata polysaccharides (BSPs), a DES system composed of choline chloride and urea in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2 molar ratio has demonstrated superior extraction efficiency. Optimization studies revealed that the highest extraction yield (55.8%) was achieved under the following conditions: extraction time of 47 minutes, temperature of 78 °C, DES water content of 35%, and solid–liquid ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]25. This represents a 36.77% improvement over conventional hot water extraction methods.39 Despite their advantages, including (1) energy efficiency, (2) environmental compatibility, (3) operational simplicity, and (4) mild extraction conditions, the application of DESs in polysaccharide extraction remains relatively unexplored. Key challenges that require further investigation include (1) comprehensive safety assessments, (2) solvent recovery and reuse strategies, and (3) the impact of DES composition on polysaccharide structure and bioactivity.

3.2. Purification method

The crude polysaccharide extract from Bletilla striata typically contains various impurities, including proteins, pigments, and inorganic salts, which must be removed to obtain purified polysaccharides for structural characterization and bioactivity studies. The purification process generally involves three main steps: deproteinization, decolorization, and fractionation. Protein removal is commonly achieved through either the Sevag method or enzymatic hydrolysis. The Sevag method,48 which involves the addition of a chloroform: n-butanol mixture (typically 4[thin space (1/6-em)]:[thin space (1/6-em)]1 v/v) to precipitate proteins, remains widely used due to its simplicity and effectiveness.49 Enzymatic methods, while more specific, may introduce additional costs and complexity. Pigment removal is typically accomplished through activated carbon adsorption or ion-exchange chromatography. The choice of method depends on the nature and concentration of the pigments present in the crude extract. Column chromatography is the most widely employed technique for polysaccharide fractionation and purification.50 Two primary chromatographic methods are commonly used: ion-exchange chromatography and gel filtration chromatography. Chen et al.20 utilized DEAE-cellulose column chromatography with gradient elution (0.1–0.5 M NaCl) to separate BSP into three fractions (BSP-1, BSP-2, and BSP-3). Peng et al.25 employed a combination of DEAE-cellulose-52 and Bio-Gel P-300 columns to purify BSPF-2, achieving high purity through sequential fractionation. The purification process typically concludes with concentration, dialysis, and lyophilization to obtain the final purified polysaccharide product.

4. Structure–activity relationship

The biological activity of plant polysaccharides is closely related to their extraction methods and structural characteristics, particularly molecular weight, monosaccharide composition, and glycosidic bond configuration.51 Research has revealed significant correlations between molecular weight and bioactivity through comparative studies of various BSPs.

Wang's study demonstrated that BSP-1 with higher molecular weight exhibited superior immune activity compared to other fractions,40 while Xu's research identified that high molecular weight pBSP possessed remarkable anti-fibrosis capabilities.52 Conversely, studies on low molecular weight fractions showed same advantages in some biological functions. In a comparative study, BSP-3 with the smallest molecular weight in a comparative study demonstrated the strongest antioxidant capacity, potentially attributed to its reduced molecular weight combined with elevated galactose and rhamnose content.20

Structural characteristics beyond molecular weight also significantly influence bioactivity. Chen's comparative analysis of four BSP types revealed that BSP-A's superior antioxidant capacity stemmed from its unique rough lamellar structure and α-glucopyranose configuration, despite not being the lowest molecular weight fraction. This study also highlighted the complex relationship between structural integrity and bioactivity, as BSP-U's molecular weight reduction through ultrasonic treatment paradoxically diminished its reducing capacity due to glycosidic bond disruption. Further supporting this structure–function relationship,5 comparative studies between pBSP and pFSP demonstrated that the latter's enhanced antioxidant activity could be attributed to its lower molecular weight and more open branched-chain architecture. These findings collectively emphasize that polysaccharide bioactivity results from the intricate interplay of multiple structural parameters.

5. Biological activity of Bletilla striata polysaccharide

5.1 Anti-inflammatory activity

Inflammation represents a fundamental immune defense mechanism triggered by various external stimuli, characterized by the release of pro-inflammatory cytokines and ROS. In vivo studies have revealed BSP's capacity to modulate cytokine production: He14 found that BSP could significantly reduce the expression levels of pro-inflammatory factors TNF-α, IL-6 and IL-1β in serum. Guo53 found that the level of inflammatory factors in rat gingivitis model treated with BSP was significantly regulated. Molecular mechanisms underlying these effects include: (1) ROS suppression: Yue et al.54 demonstrated BSPb's inhibition of Ang II-induced ROS generation. (2) Cytokine regulation: downregulation of pro-inflammatory mediators (IL-6, TNF-α)54,55 and upregulation of tight junction proteins (ZO-1, occludin) for mucosal protection.56 In addition, Wang's research found that Bletilla striata polysaccharide can induce the proliferation and immune enhancement of vascular endothelial cells and growth factors, act on macrophages and stimulate the expression of pro-inflammatory cytokines.57 These findings collectively suggest that BSPs exert anti-inflammatory effects through a complex network of immunomodulatory actions, making them promising candidates for inflammatory disorder management.

5.2. Hemostatic activity

Hemostasis is a vital physiological process that prevents excessive blood loss through coordinated mechanisms including vasoconstriction, platelet activation, coagulation cascade initiation, and fibrin clot formation. Growing evidence suggests that BSPs exhibit significant hemostatic properties, although their precise molecular mechanisms require further elucidation. Current research has demonstrated that BSPs promote hemostasis through multiple pathways. Hung et al.58 identified water-soluble BSP as a key mediator in accelerating hemostatic responses, highlighting its potential clinical utility. Further mechanistic studies by Dong et al.59 revealed that BSP at concentrations of 50–200 mg L−1 significantly enhances platelet aggregation in rat PRP in a concentration-dependent manner. This effect appears to be mediated through activation of the ADP receptor signaling pathway, specifically involving P2Y1 and P2Y12 receptors, as well as PKC, leading to platelet shape change, granule secretion, and subsequent aggregation. Additional evidence from Guo et al.53 supports these findings, showing that BSPS effectively promote platelet aggregation and accelerate clot formation in rat gingivitis models. These observations suggest that BSPs may function through both physical adhesion properties and biochemical modulation of coagulation pathways. The mucoadhesive nature of BSPs likely facilitates platelet adhesion at injury sites, while potential interactions with fibrinogen or von Willebrand factor may contribute to clot stabilization. The promising hemostatic properties of BSPs position them as attractive candidates for various clinical applications, including surgical hemostatic agents, emergency trauma care products, and adjuncts for bleeding disorders. However, several key questions remain unanswered regarding their exact molecular targets, potential synergies with existing hemostatic agents, and the influence of structural modifications on activity.

5.3. Wound healing

Wound healing is a series of complex processes for the body to repair and regenerate injured tissues, involving hemostasis, inflammation, cell regeneration, tissue remodeling and other processes. Guo et al.53 found that the sulfate of BSPS can induce PLA2, promote the release of AA in the blood to increase TXB2, thereby promoting platelet aggregation. In the study of insulin wound healing, Zhao et al.60 found that BSP can inhibit macrophage infiltration and NLRP3 inflammasome activation, reduce IL-1β expression level and promote angiogenesis. These results show that BSP has the ability to promote wound healing. Zhang et al.61 found that BSP hydrogel can promote re-epithelialization and collagen deposition, and accelerate wound healing by activating TGF-β/Smad signaling pathway. The experimental results of He showed that the wound healing rate of the BSP treatment group was close to 85% on the 9th day after injury, which was nearly 20% higher than that of the control group, which also indicated that BSP had the ability to promote wound healing.14 Wu et al.62 's study found that BSP can down-regulate the expression of SCEL gene, significantly reduce LPS-induced HMEC-1 cell injury and promote wound healing by promoting cell survival, reducing apoptosis, enhancing migration and angiogenesis.

5.4. Antioxidant activity

Oxidative stress, resulting from an imbalance between ROS production and antioxidant defenses, plays a critical role in various pathological processes. The antioxidant properties of BSPs have been extensively investigated, demonstrating their potential as natural antioxidants. Chen et al.5 conducted a comprehensive comparative study evaluating the antioxidant capacity of BSPs extracted through four distinct methods. Their findings revealed significant variations in free radical scavenging capabilities against DPPH, ABTS, and hydroxyl radicals among the different BSP preparations. These differences were attributed to extraction method-dependent modifications in polysaccharide structure and composition, suggesting that the extraction process significantly influences the antioxidant potential of BSPs. Further evidence from He et al.14 demonstrated the in vivo antioxidant effects of BSP in murine models. Treatment with BSP resulted in a marked increase in SOD activity in both serum and liver tissues, accompanied by significant reductions in NO and MDA levels. These results demonstrate that the mechanisms by which BSP regulates oxidative stress include: (1) direct scavenging of free radicals; (2) enhancing the activity of endogenous antioxidant enzyme systems; (3) inhibiting lipid peroxidation; (4) regulating endogenous NO metabolism. The observed modulation of oxidative stress markers suggests that BSPs may offer therapeutic potential in diseases associated with oxidative damage.

5.5. Antimicrobial activity

Currently, research on the antibacterial activity of Bletilla striata polysaccharides is relatively limited. However, existing studies have demonstrated that these polysaccharides possess antibacterial activity against both Gram-positive and Gram-negative pathogens. Li et al.63 reported concentration-dependent bactericidal activity against Staphylococcus aureus (6.25–12.50 mg mL−1), with mechanistic studies suggesting membrane permeability alteration as a potential mode of action. These findings were extended by Dai et al.,64 who demonstrated inhibitory effects against Escherichia coli, Proteus spp., Staphylococcus aureus, and Bacillus subtilis, with enhanced efficacy observed at 20 mg mL−1. The consistent observation of membrane permeability changes across studies suggests this may represent a fundamental antibacterial mechanism of BSPs.

5.6. Other activities

Beyond its established biological activities, BSPs exhibit a broad spectrum of pharmacological effects, including immunomodulatory activity, anti-tumor activity65–67 and anti-fibrosis effect,27,68 as demonstrated by various in vitro and in vivo studies.

Immunomodulatory studies have revealed significant effects of BSPs on immune cell function. Peng et al. observed that BSP treatment could modulate the lifespan of Pseudomonas aeruginosa-infected nematodes and exert thymus-dependent immunoregulatory effects in mice, with BSPF2 demonstrating particularly potent activity in stimulating murine spleen cell proliferation.25 Complementary findings by Liu et al. showed that BSAP administration in tumor-bearing rats provided protective effects on thymus and spleen organs while enhancing macrophage activity, lymphocyte proliferation, and NK cell function, along with favorable modulation of lymphocyte subpopulations.21

6. BSP-based composite biomaterials: benefiting from BSP bioactivity

While bioactive components with pharmacological effects offer therapeutic potential, their clinical application is often limited when used in isolation. To address these limitations and meet clinical requirements, the development of composite biomaterials has emerged as a promising strategy. In biomedical research, composite biomaterials have gained significant attention due to their ability to integrate the advantages of multiple components through physical or chemical crosslinking, thereby overcoming the constraints of individual materials while enhancing overall functionality. The growing recognition of BSPs diverse biological activities has spurred increasing interest in their incorporation into composite biomaterials for advanced biomedical applications. Recent studies have focused on developing BSP-based composite systems that leverage its inherent bioactivity while combining it with other functional materials to achieve synergistic effects. Currently, several composite biomaterials containing BSP have been studied, including gel-based biomaterials for wound healing and drug delivery, hemostatic cotton formulations for rapid blood coagulation, microneedle systems for transdermal applications, composite eye drops for ophthalmic treatment, and film materials with good mechanical properties. These composite materials capitalize on BSP's unique properties while addressing specific clinical needs. Table 3 provides a comprehensive overview of current BSP-based composite biomaterials, including their compositions, fabrication methods, and intended applications. The development of such composite systems represents an important step toward translating BSP's pharmacological potential into clinically viable products, with ongoing research focusing on optimizing material properties, enhancing bioactivity, and ensuring safety for human use. Future directions include the exploration of novel composite formulations and the refinement of fabrication techniques to further expand BSP's biomedical applications.
Table 3 Composite biomaterials based on the biological activity of BSP
Name Biomaterial compositions Crosslinking Property Application potential Ref.
Gels
Methacrylate-modified chitosan and ferulic acid and OBSP combined multi-functional spray hydrogel Methacrylate-modified chitosan; ferulic acid; OBSP Chemical photocrosslinking Antibacterial activity; biocompatibility; antioxidant activity; hemostatic activity Spray-based hydrogel for promoting wound healing 81
Bletilla striata polysaccharide/chitosan hydrogel BSP; chitosan Chemical crosslinking of schiff base reaction Biodegradability; biocompatibility Hydrogel nanoparticles 83
A dual network cross-linked hydrogel with multifunctional Bletilla striata polysaccharide/gelatin/tea polyphenol OBSP; tea polyphenol; adipic acid dihydrazide modified gelatin Chemical crosslinking of schiff base reaction Antioxidant; antimicrobial; hemostatic properties Double network crosslinked hydrogel for promoting wound healing 95
Ligand-selective targeting of macrophage hydrogel BSP; gelatin; mesoporous bioactive glass Chemical crosslinking of schiff base reaction Biocompatibility; promoting intraosseous; self-repair Macrophage hydrogel 84
A blend hydrogel of polysaccharide BSP; curdlan-based hydrogel Physical crosslinking of heating-cooling Biocompatibility; wound healing Curdlan-based hydrogel for wound healing 85
A multifunctional herb-derived glycopeptide hydrogel OBSP; gallic acid-grafted -polylysine; dpaeoniflorin-loaded micelles Chemical crosslinking of schiff base reaction Injectability; self-healing; biocompatibility Multifunctional herb-derived glycopeptide hydrogel 96
Multi-functional dual network polysaccharide hydrogel OBSP; gallic acid grafted chitosan Schiff base and pyrogallol-Fe3+ Self-healing; biocompatibility; Dual network polysaccharide hydrogel adhesive 80
Physical dual-network photothermal antibacterial multifunctional hydrogel BSP-U; dopamine-conjugated di-aldehyde-hyaluronic linked with Fe3+ Chemical cross-linking of Fe3+ under alkaline conditions Anti-oxidant; biocompatibility; Multifunctional hydrogel adhesive 97
Deformable sodium alginate/Bletilla striata polysaccharide in situ gel Sodium alginate; deacetylated gellan gum; calcium citrate; BSP Physical crosslinking of heating and cooling Deformability; mechanical resistance; bioadhesion; gastric retentiondpaeoniflorin Gastric acid-sensitive in situ gel 78
A self-healing hydrogel wound dressing based on oxidized Bletilla striata polysaccharide and cationic gelatin OBSP; cationic gelatin Chemical crosslinking of schiff base reaction Hemostatic activity; antioxidant activity Hydrogel wound dressing 98
A rapid-floating natural polysaccharide gel–raft BSP; glyceryl monooleate Physical crosslinking by swelling method Anti-inflammatory activity; suspension; Polysaccharide raft for the treatment of gastroesophageal reflux disease 71
Mussel-inspired pH-responsive hydrogel based on Bletilla striata polysaccharide Carboxymethylated BSP-dopamine conjugate Chemical crosslinking of NaIO4 oxidation Cytocompatibility; hemocompatibility; antioxidant activity; antibacterial properties As a PH-responsive drug release agent 99
[thin space (1/6-em)]
Sponges
Bletilla striata polysaccharide and chitosan composite hemostatic sponge (BSP–CS) BSP; chitosan Chemical cross-linking of oxalyl chloride Antibacterial activity; hemostatic activity Hemostatic sponge 76
Bletilla striata polysaccharide collagen sponge EBSP; collagen Chemical crosslinking catalyzed by alkaline Blood compatibility; cytocompatibility As a new hemostatic sponge material 86
[thin space (1/6-em)]
Microneedles
Multifunctional natural microneedles based methacrylated Bletilla striata polysaccharide Peony leaf extract; fmethacrylated Bletilla striata polysaccharide; methacrylated chitosan Chemical photocrosslinking Antimicrobial activity; mechanical properties; biocompatibility; For the treatment of infectious wound dressings 75
Bilayer microneedles based on Bletilla striata polysaccharide containing asiaticoside Asiaticoside; BSP/(CS) com- posite bilayer dissolvable microneedles — Antibacterial; biocompatibility; biodegradability Improve skin regeneration and inhibit scar formation 87
Chitosan/BSP composited microneedles Chitosan; tannic acid; AgNO3; BSP — Anti-inflammatory activity; antioxidant activity; anti-biofilm properties Composited microneedles for infected and susceptible wound healing 100
Bletilla striata polysaccharide microneedles Hyaluronic acid; polyvinyl alcohol; BSP — Stability; biocompatibility; safety Bletilla striata polysaccharide microneedle for transdermal delivery of the vaccine 101
Novel Bletilla striata polysaccharide microneedles — — Stability; moldability; safety As a new transdermal drug delivery route 102
A microneedlemediated biomimetic transdermal drug delivery system — — Physical stability; mechanical strength An active targeted drug delivery system for the local treatment of hypertrophic scar fibroblasts 103
[thin space (1/6-em)]
Eye drops
Oxidized Bletilla striata polysaccharide-natamycin eye drops BSP; NAP Chemical crosslinking of schiff base reaction Biocompatibility; anti-inflammatory activity; safety As a compound eye drops for the treatment of deep eye ulcers 73
Levofloxacin-BSP eye drops BSP; — Antibacterial; biocompatibility; As a local eye drug delivery carrier 91
levofloxacin
[thin space (1/6-em)]
Films
BSP/WPU nanofiber membrane BSP; waterborne polyurethane — Anti-inflammatory activity; biocompatibility Nerve wrapping membrane for peripheral nerve repair 92
BSP/PLA film BSP; polylactic acid Physical blending with 1,4-dioxane and ultrapure water as solvent Mechanical strength; stability New heat-resistant, low-cost and environmentally friendly composite film 93
pH/enzyme dual sensitive Gegenqinlian pellets coated with Bletilla striata polysaccharide membranes BSP — Anti-inflammatory activity; mechanical strength; stability Protective film for drug delivery 94

6.1. Physicochemical property

As a typical plant-derived polysaccharide, BSP exhibits excellent biocompatibility and biodegradability; it can be enzymatically degraded into monosaccharides and completely metabolized in vivo, eliminating the risk of by-product accumulation and providing a prerequisite for its use as an implantable biomaterial. CCK-8 cytotoxicity assays showed no significant cytotoxic or inhibitory effects on IEC-18 cells at concentrations of 25, 50 and 100 µg mL−1, demonstrating good biosafety.56 Moreover, comparative studies reveal that BSP-based biomaterials offer a markedly superior safety profile to conventional materials.69

BSP is composed mainly of mannose and glucose, and its side chains are rich in hydroxyl groups with a small number of carboxyl and amino substituents. This structure endows the polysaccharide with excellent hydrophilicity and multiple cross-linking options: periodate oxidation rapidly generates aldehyde groups that undergo Schiff-base gelation with amino-bearing polymers within seconds, while methacrylation enables photo-cross-linking under specific light doses. The viscosity of BSP solutions increases with molecular weight, and film strength rises accordingly, allowing mechanical properties to be tuned for a variety of applications.70 In addition to its favorable rheological profile, BSP exhibits inherent mucoadhesivity, offering the potential for prolonged residence and targeted interaction with mucosal tissues. The 3D helical conformation of BSP exposes numerous hydroxyl and ether-oxygen groups, enabling multipoint hydrogen bonding with mucins for robust mucosal adhesion, while the central helical cavity can simultaneously encapsulate hydrophobic drugs, integrating firm attachment and drug-loading functions in a single platform.71 Pharmacologically, as outlined earlier, extensive studies have demonstrated that BSP possesses potent anti-inflammatory, repair-promoting and antimicrobial activities. Whether used alone as the principal therapeutic ingredient or as a functional excipient, it offers significant value; detailed bioactivity applications will be elaborated in the following sections according to biomaterial categories.

In short, both its physicochemical behavior and chemical structure underscore BSP as a highly promising raw material for biomaterial synthesis.

6.2. Cross-link

The dense array of hydroxyl groups and oxidizable vicinal diols on the BSP backbone provides the key reactive handles for cross-linking: oxidation furnishes aldehydes for Schiff-base covalent assembly, hydroxyls can be esterified to form covalent ester bonds, and the same diol/carboxylic motifs coordinate multivalent metal ions. Both physical and chemical cross-linking pathways are therefore accessible during BSP biomaterial fabrication; the detailed mechanisms are elaborated in the following two sections.
6.2.1. Chemical cross-link. Chemical crosslinking is a key strategy for integrating two or more individual polymers into a composite, imparting enhanced stability and mechanical strength through covalent bonding while preserving biocompatibility.71 The Schiff-base reaction is a widely employed chemical cross-linking strategy in which primary amines condense with aldehyde or ketone groups at neutral pH to form reversible imine bonds. Dehydration-driven and dynamically cleavable within the tissue micro-environment, these imine linkages endow hydrogels and scaffolds with both degradability and cytocompatibility.72,73 Photocrosslinking is another prevalent chemical cross-linking modality: a photoinitiator activated by a specific wavelength generates reactive radicals that rapidly form covalent bonds with polymer chains, yielding no by-products and completing within seconds.74,75 Oxalyl chloride-mediated covalent cross-linking has also been exploited by several groups, the reaction proceeds without residual aldehydes and exhibits minimal cytotoxicity, making it an advantageous cross-linking tool for hemostatic sponges.76
6.2.2. Physical cross-link. In contrast to chemical cross-linking, physical cross-linking assembles three-dimensional polymer networks through non-covalent interactions—hydrogen bonding, electrostatic attraction, ionic coordination and so forth. Operating under mild conditions, it leaves no chemical residues and offers reversible, stimuli-responsive behavior. These features make it the method of choice for biologically demanding applications such as biodegradable hemostats, injectable hydrogels, and gastric floating rafts.77 Physical cross-linking via heating–cooling disrupts pre-existing hydrogen bonds at elevated temperature and rebuilds them during subsequent cooling, enabling a reversible “sol-on-heating, gel-on-cooling” transition.78 Physical cross-linking via the swelling approach allows pre-existing junctions within a dry network to rearrange and densify upon hydration, forming additional hydrogen bonds that convert a dry wafer into a hydrogel in a single step.71 Metal-ion coordination cross-linking—although it creates chemical coordinate bonds—operates with bond energies far below those of covalent linkages and is therefore classified as a physical cross-linking strategy.79,80

6.3. Biomaterials

6.3.1. Gels. Hydrogels have emerged as particularly promising platforms for clinical wound healing applications due to their tunable physical properties and ability to mimic the extracellular matrix. These three-dimensional networks can be fabricated through various crosslinking strategies, including thermal-induced gelation, photo-crosslinking, and chemical conjugation. Among these, chemical crosslinking via Schiff base formation between amine groups and oxidized polysaccharides has become a predominant approach for creating BSP-based hydrogels, owing to its mild reaction conditions and reversible imine bonding.

Recent advances in BSP hydrogel design have yielded sophisticated systems with multifunctional capabilities. Zhong et al.81 developed an innovative sprayable hydrogel system through the Schiff base reaction between OBSP and methacrylate-modified chitosan/ferulic acid complexes. This dynamic hydrogel demonstrated exceptional performance in irregular wound management, combining antibacterial, antioxidant, and hemostatic properties with controlled degradability. Yang82's subsequent modification incorporating plant-derived bacilli further enhanced the antimicrobial efficacy of this platform, showcasing the versatility of this design approach.

For gastrointestinal applications, researchers have engineered temperature-sensitive adhesive hydrogels by crosslinking oxidized BSP with chitosan and β-glycerophosphate. This intelligent system undergoes rapid sol–gel transition at physiological temperatures, forming a nanoparticle-loaded hydrogel that adheres effectively to ulcerative colitis lesions while prolonging drug release through enhanced mucosal retention. The system's prolonged residence time in the harsh gastrointestinal environment represents a significant advancement in local drug delivery for inflammatory bowel disease.83

In bone tissue engineering, Wang et al.84 created a novel GBMgel through Schiff base-mediated self-assembly. This composite material demonstrates unique immunomodulatory properties, capable of macrophage recruitment and polarization through modulation of TLR4/NF-κB, MAPK, and JAK/STAT3 signaling pathways. The resulting pro-regenerative immune microenvironment promotes osteogenic differentiation and bone defect repair, highlighting BSP's potential in immunoinstructive biomaterials.

Simpler yet effective systems have also been developed, such as Shang85's thermally crosslinked BSP-curdlan blend hydrogel. This straightforward preparation yields materials with excellent biocompatibility and wound healing performance, demonstrating that even minimally processed BSP composites can achieve significant therapeutic effects. The versatility of BSP-based hydrogels is further evidenced by their capacity for functional augmentation through incorporation of antimicrobial agents, growth factors, or other therapeutic compounds. This modular design approach enables precise tailoring of material properties to meet specific clinical requirements, paving the way for personalized wound care solutions. Current research continues to explore novel combinations of BSP with both natural and synthetic polymers to optimize mechanical properties, degradation kinetics, and bioactive compound release profiles for enhanced therapeutic outcomes.

6.3.2. Sponges. Effective hemostasis represents the critical first phase of successful wound healing, and advanced hemostatic materials must combine rapid clotting capability with biocompatibility to minimize complications. Hemostatic sponges have emerged as particularly valuable in this regard, offering the dual advantages of traditional coagulation promotion coupled with superior fluid absorption capacity for blood and wound exudates.

Recent innovations in BSP-based sponge composites have significantly advanced hemostatic material performance. Zhang et al.76 developed a novel chitosan-BSP composite sponge through oxalyl chloride-mediated crosslinking, which demonstrated marked improvements over conventional gauze across multiple hemostatic parameters. Experimental evaluations revealed superior performance in: hemostasis time, in vitro coagulation time, blood loss volume and antimicrobial activity. parallel work by Tang et al.86 employed an alternative chemical strategy, creating EBSP for crosslinking with collagen under alkaline conditions. The resulting EBSP-collagen sponge exhibited exceptional blood and cell compatibility while maintaining robust hemostatic performance. Comparative studies with standard gauze demonstrated: enhanced platelet adhesion and activation, improved fibrin network formation, reduced inflammatory response and sustained structural integrity in wet conditions.

Although hemostatic sponges have been commonly used hemostatic materials, it is still meaningful to study new composite sponges on the basis of traditional hemostatic sponge materials, which can solve the problems of limited hemostatic efficiency, poor biocompatibility and infection risk of traditional sponges.

6.3.3. Microneedles. Microneedle arrays represent an innovative transdermal drug delivery platform that overcomes the skin's formidable barrier properties while avoiding the pain associated with conventional hypodermic injections. These microscale devices create temporary conduits through the stratum corneum, enabling efficient drug transport to subcutaneous tissues while minimizing tissue damage. Recent developments have incorporated BSP into microneedle systems, capitalizing on its unique physicochemical and biological properties to enhance therapeutic outcomes.

Lv et al.87 engineered a sophisticated bilayer soluble microneedle system composed of BSP and CS for AS delivery. This design addressed AS's pharmacological limitations – poor water solubility and suboptimal lipophilicity – by utilizing BSP as both a drug carrier and functional excipient. The CS-AS-BSP microneedles demonstrated controlled drug release kinetics while providing complementary anti-inflammatory and tissue repair benefits from BSP. Comprehensive in vitro and in vivo evaluations confirmed the system's excellent antibacterial properties, biocompatibility, and biodegradability, establishing a promising platform for scar prevention and wound management. Further advancing this technology, Ye et al.75 developed a photocrosslinkable microneedle system using BSPMA and CSMA incorporated with PLE. The resulting BCP-MN composite exhibited exceptional mechanical properties for reliable skin penetration while maintaining structural integrity during drug delivery. This multifunctional system addressed key challenges in treating deep skin infections through its demonstrated capabilities in bacterial inhibition and reactive oxygen species scavenging. The incorporation of BSPMA provided enhanced structural stability and bioactive functionality compared to conventional microneedle formulations.

As a new type of composite material, microneedle has less research on its clinical application than other biomaterials. Its unique physical structure can achieve subcutaneous high-efficiency treatment and has good application prospects.

6.3.4. Eye drops. The BSP in ophthalmic drug delivery has emerged as a promising strategy to overcome the challenges of conventional ocular treatments. Despite the extensive study of polysaccharides for ocular applications,88,89 however, there are few studies based on BSP. Recent studies have demonstrated the potential of BSP to improve the efficacy of ocular drugs, particularly in treating deep corneal infections that are difficult to manage with traditional formulations.

A significant advancement was achieved by Tian et al.,73 who developed OBN through Schiff base crosslinking. This innovative formulation addressed the major limitations of natamycin, a potent antifungal agent whose clinical use has been restricted by poor water solubility and inadequate penetration into the corneal stroma. The OBN system not only enhanced drug solubility but also facilitated deeper tissue penetration, significantly improving therapeutic outcomes in fungal keratitis. Similarly, Wu et al.90,91 demonstrated that combining BSP with levofloxacin resulted in superior antibacterial efficacy against Staphylococcus aureus-induced keratitis compared to levofloxacin alone. The BSP component was shown to promote drug penetration into the corneal stroma while contributing additional pharmacological benefits.

The effectiveness of BSP in ocular drug delivery stems from its unique physicochemical properties. Its mucoadhesive nature prolongs residence time on the ocular surface, while its structural characteristics enhance drug permeation across corneal barriers. Furthermore, safety studies involving subconjunctival injection of BSP have confirmed its excellent tissue compatibility, supporting its potential as a safe and effective carrier for ocular therapeutics. These findings highlight the versatility of BSP-based formulations, which could be adapted for various ocular conditions, including bacterial and fungal infections, as well as inflammatory disorders.

6.3.5. Film. Composite films incorporating BSP have demonstrated remarkable potential in biomedical applications due to their enhanced stability and tunable mechanical properties. Recent developments in BSP-based film technologies have yielded materials with multifunctional capabilities, ranging from neural regeneration to gastrointestinal therapeutics.

Chen et al.92 engineered a novel nanofiber membrane (NFM) by combining BSP with water-based polyurethane (WPU), creating a composite material that synergistically combines structural support with biological activity. This innovative membrane demonstrated significant benefits in peripheral nerve repair, where it promoted Schwann cell proliferation and axon regeneration while preventing tissue adhesion. The dual functionality of the BSP-WPU composite – providing both mechanical guidance and anti-inflammatory support – represents a substantial advancement in neural tissue engineering materials. Yang et al.93 developed a BSP-polylactic acid (PLA) composite film through solvent blending techniques. This formulation exhibited notable improvements in thermal stability and mechanical performance, with a significant elevation in glass transition temperature compared to pure PLA. The enhanced tensile strength and thermal properties of this biocomposite suggest promising applications in medical devices and packaging where both durability and biodegradability are required. Sun94's work on pH/enzyme dual-responsive drug delivery systems showcased another innovative application of BSP films. By coating Gegen Qinlian pellets with BSP, researchers created an intelligent delivery vehicle for treating gastrointestinal ulcers. The BSP coating not only provided robust mechanical protection but also contributed anti-inflammatory activity to the therapeutic payload. This system's ability to respond to both pH changes and enzymatic activity in the gastrointestinal tract demonstrates the versatility of BSP-based films in controlled drug delivery applications. The development of these advanced film materials highlights BSP's unique capacity to enhance both the physical properties and biological functionality of biomedical composites.

Regarding the clinical application potential of composite materials synthesized from different materials, Fig. 3 provides visual presentation and support.


image file: d5ra06806a-f3.tif
Fig. 3 Application potential and mechanism of action of bio-materials based on the bioactivity of BSPs.

7. Conclusion and prospect

As a medicinal plant that has been used in traditional Chinese medicine for thousands of years, Bletilla striata has garnered increasing scientific interest due to its rich bioactive components, particularly BSPs. These polysaccharides exhibit a complex structural configuration, including the characteristic triple-helix conformation, though their complete structural elucidation remains an active area of research. The extraction of BSP has evolved from conventional methods such as hot water and alkaline extraction to more advanced techniques, including ultrasound-, microwave-, infrared-, and enzyme-assisted approaches. While these modern methods offer improved efficiency and reduced environmental impact, they also present challenges such as equipment costs and process optimization. The integration of multiple techniques in hybrid extraction shows potential for increasing yield while maintaining biological activity, thus paving the way for more sustainable and scalable production methods. The integration of multiple techniques in hybrid extraction shows potential for increasing yield while maintaining biological activity, thus paving the way for more sustainable and scalable production methods.

The pharmacological potential of BSP is vast, with demonstrated efficacy in anti-inflammatory, wound healing, hemostatic, and antioxidant applications. Recognizing the limitations of BSP in isolation, researchers have increasingly turned to composite biomaterials—such as hydrogels, sponges, microneedles, eye drops and films—that integrate BSP with other functional components to enhance bioactivity and mechanical properties. These advanced materials exhibit excellent biocompatibility, anti-infection capabilities, and tissue repair promotion, offering significant improvements over traditional wound treatments. Moreover, they hold promise for personalized medicine by enabling tailored therapeutic solutions.

Despite these advancements, the path to clinical adoption necessitates rigorous evaluation of safety, environmental impact, and long-term efficacy. Future research should focus on standardizing extraction and fabrication protocols, optimizing material performance for specific medical applications, and conducting comprehensive preclinical and clinical validations. Additionally, exploring novel applications in drug delivery, regenerative medicine, and immune modulation could further expand the utility of BSP-based biomaterials. By addressing these challenges, BSP-derived composites have the potential to revolutionize wound care and other biomedical fields, bridging traditional medicine with modern therapeutic innovation.

Author contributions

J. F.: writing—original draft preparation; Y. L.: writing—review; N. X., K.·H.: investigation; T. C.: editor; S.·C., R. F.: supervision and conceptualization. All authors have read and agreed to the published version of the manuscript.

Conflicts of interest

There are no conflicts to declare.

Abbreviations

ASAsiaticoside
ABTS3-Ethylbenzothiazoline-6-sulphonic acid
BSPMAMethacrylated Bletilla striata polysaccharide
BBDBox–Behnken design
CSMAMethacrylated chitosan
CSChitosan
DESsDeep eutectic solvents
DPPH1,1-Diphenyl-2-picrylhydrazyl
EBSPEpoxy Bletilla striata polysaccharide
GPCGel permeation chromatography
GlcGlucose
GalGalactose
GCGas chromatography
GA-BPGenetic algorithm-back-propagation
GBMgelGelatin-Bletilla striata polysaccharide-mesoporous bioactive glass hydrogel
GC-MSGas chromatography-mass spectrometry
HBDsHydrogen bond donors
HBAsHydrogen bond acceptors
HMEC-1Human microvascular endothelial cells
HPGPCHigh-performance gel permeation chromatography
ICIon chromatography
JAK/STAT3Janus kinase/signal transducer and activator of transcription 3
LPSLipopolysaccharide
MnNumber-average molecular weight
MwWeight-average molecular weight
MALLSMulti-angle laser light scattering
ManMannose
MAPKMitogen-activated protein kinase
MDAMalondialdehyde
NKNatural killer
NMRNuclear magnetic resonance
NFMNanofiber membrane
NONitric oxide
OBSPOxidized BSP
OBNOxidized Bletilla striata polysaccharide-natamycin conjugates
PRPPlatelet-rich plasma
PKCProtein kinase C
PLEPeony leaf extract
PLAPolylactic acid
RIRefractive index
RSMResponse surface methodology
ROSReactive oxygen species
SECSize exclusion chromatography
SCELSynaptopodin-2-like gene
SODSuperoxide dismutase
WPUWater-based polyurethane
XylXylose

Data availability

No primary research results, software or code have been included and no new data were generated or analysed as part of this review.

Acknowledgements

This research was funded by the National Natural Science Foundation of China (No. 82304714, 330020057), PhD Start-up Foundation of Liaoning Province (2024-BS-274), Basic Research Projects of Liaoning Provincial Department of Education (No. JYTMS20231406), Liaoning Province Science and Technology Innovation Team Project (No. LJ222410164015) and National College Student Innovation Training Project, China (No. 20239007).

References

  1. K. W. Tan, Brittonia, 1969, 21, 202–214 CrossRef.
  2. E. C. O. F. R. P. Sinicae, Flora Reipublicae Popularis Sinicae, Science Press, Beijing, 1999 Search PubMed.
  3. S. Jiang, M. Wang, L. Jiang, Q. Xie, H. Yuan, Y. Yang, S. Zafar, Y. Liu, Y. Jian, B. Li and W. Wang, J. Ethnopharmacol., 2021, 280, 114263 CrossRef CAS PubMed.
  4. W. Zhai, E. Wei, R. Li, T. Ji, Y. Jiang, X. Wang, Y. Liu, Z. Ding and H. Zhou, ACS Omega, 2021, 6, 656–665 CrossRef CAS PubMed.
  5. H. Chen, J. Zeng, B. Wang, Z. Cheng, J. Xu, W. Gao and K. Chen, Carbohydr. Polym., 2021, 266, 118149 CrossRef CAS PubMed.
  6. H. Diao, X. Li, J. Chen, Y. Luo, X. Chen, L. Dong, C. Wang, C. Zhang and J. Zhang, J. Biosci. Bioeng., 2008, 105, 85–89 CrossRef CAS PubMed.
  7. X. Yang, C. Tang, P. Zhao, G. Shu and Z. Mei, Planta Med., 2012, 78, 606–610 CrossRef CAS PubMed.
  8. W. Wang and H. Meng, Fitoterapia, 2015, 101, 12–18 CrossRef CAS PubMed.
  9. Y. Shi, B. Zhang, Y. Lu, C. Qian, Y. Feng, L. Fang, Z. Ding and D. Cheng, BMC Complementary Altern. Med., 2017, 17, 273 CrossRef PubMed.
  10. A. Sun, J. Liu, S. Pang, J. Lin and R. Xu, Bioorg. Med. Chem. Lett., 2016, 26, 2375–2379 CrossRef CAS PubMed.
  11. B. Wang, H. Zhang, L. Chen, Z. Mi, Y. Xu and G. Zhao, Carbohydr. Polym., 2020, 246, 116620 CrossRef CAS PubMed.
  12. G. Jiang, B. Wang, Y. Wang, H. Kong, Y. Wang, P. Gao, M. Guo, W. Li, J. Zhang, Z. Wang and J. Niu, Carbohydr. Polym., 2023, 313, 120781 CrossRef CAS PubMed.
  13. C. L. Lee, Y. L. Jhan, H. M. Chiang and C. J. Chen, Nat. Prod. Res., 2024, 38, 3848–3853 CrossRef CAS PubMed.
  14. X. He, L. Liu, F. Gu, R. Huang, L. Liu, Y. Nian, Y. Zhang and C. Song, Int. J. Biol. Macromol., 2024, 261, 129874 CrossRef CAS PubMed.
  15. I. Kwiecień and M. Kwiecień, Gels, 2018, 4(2), 47 CrossRef PubMed.
  16. Q. Li, Y. Niu, P. Xing and C. Wang, Chin. Med., 2018, 13, 7 CrossRef PubMed.
  17. X. He, X. Wang, J. Fang, Z. Zhao, L. Huang, H. Guo and X. Zheng, J. Ethnopharmacol., 2017, 195, 20–38 CrossRef CAS PubMed.
  18. Z. Zhu, T. Liang, G. Dai, J. Zheng, J. Dong, C. Xia and B. Duan, Int. J. Biol. Macromol., 2023, 245, 125407 CrossRef CAS PubMed.
  19. J. Xu, S. L. Li, R. Q. Yue, C. H. Ko, J. M. Hu, J. Liu, H. M. Ho, T. Yi, Z. Z. Zhao, J. Zhou, P. C. Leung, H. B. Chen and Q. B. Han, Anal. Bioanal. Chem., 2014, 406, 6409–6417 CrossRef CAS PubMed.
  20. H. Chen, Y. Wu, B. Wang, M. Kui, J. Xu, H. Ma, J. Li, J. Zeng, W. Gao and K. Chen, Int. J. Biol. Macromol., 2024, 262, 130016 CrossRef CAS PubMed.
  21. C. Liu and A. J. Liu, Chem. Biodiversity, 2022, 19, e202200635 CrossRef CAS PubMed.
  22. J. Qiu, X. Xu, J. Guo, Z. Wang, J. Wu, H. Ding, Y. Xu, Y. Wu, Q. Ying, J. Qiu, S. Wu and S. Shi, Int. J. Biol. Macromol., 2024, 263, 130267 CrossRef CAS PubMed.
  23. F. Huang, Y. Fan, X. Liu, Y. Chen, Y. Huang, Y. Meng and Y. Liang, Int. J. Biol. Macromol., 2024, 273, 133206 CrossRef CAS PubMed.
  24. Z. Chen, Y. Zhao, M. Zhang, X. Yang, P. Yue, D. Tang and X. Wei, Carbohydr. Polym., 2020, 227, 115362 CrossRef CAS PubMed.
  25. Q. Peng, M. Li, F. Xue and H. Liu, Carbohydr. Polym., 2014, 107, 119–123 CrossRef CAS PubMed.
  26. Y. Li, Y. Hao, X. Yang, J. Zhao, R. Chang, B. Wang and X. Zhan, Int. J. Biol. Macromol., 2025, 307, 141904 CrossRef CAS.
  27. Y. Wang, D. Liu, S. Chen, Y. Wang, H. Jiang and H. Yin, Fitoterapia, 2014, 92, 72–78 CrossRef CAS PubMed.
  28. C. Wang, J. Sun, Y. Luo, W. Xue, H. Diao, L. Dong, J. Chen and J. Zhang, Biotechnol. Lett., 2006, 28, 539–543 CrossRef CAS PubMed.
  29. M. Zhao, Z. Guan, N. Tang and Y. Cheng, Int. J. Biol. Macromol., 2023, 235, 123925 CrossRef CAS PubMed.
  30. H. Chen, B. Wang, J. Li, J. Xu, J. Zeng, W. Gao and K. Chen, Int. J. Biol. Macromol., 2023, 226, 982–995 CrossRef CAS PubMed.
  31. J. Ai, Z. Yang, J. Liu, H. A. Schols, M. Battino, B. Bao, L. Tian and W. Bai, J. Agric. Food Chem., 2022, 70, 3654–3665 CrossRef CAS PubMed.
  32. X. Han, H. Liu, Y. Zhang, Y. Zhang, Z. Song, L. Yang, X. Liu, L. Yang, M. Wu and L. Tan, Prep. Biochem. Biotechnol., 2024, 1–11,  DOI:10.1080/10826068.2024.2419862.
  33. J. H. Sun, J. S. Shi, D. F. Sun and W. M. Zhang, Food Sci., 2009, 30, 5 Search PubMed.
  34. L. Shen, S. Pang, M. Zhong, Y. Sun, A. Qayum, Y. Liu, A. Rashid, B. Xu, Q. Liang, H. Ma and X. Ren, Ultrason. Sonochem., 2023, 101, 106646 CrossRef CAS PubMed.
  35. A. Delazar, L. Nahar, S. Hamedeyazdan and S. D. Sarker, Methods Mol. Biol., 2012, 864, 89–115 CrossRef CAS PubMed.
  36. C. H. Zhang, Y. H. Yun, W. Fan, Y. Z. Liang, Y. Yu and W. X. Tang, Int. J. Biol. Macromol., 2015, 79, 983–987 CrossRef CAS PubMed.
  37. Y. Qu, C. Li, C. Zhang, R. Zeng and C. Fu, Carbohydr. Polym., 2016, 148, 345–353 CrossRef CAS PubMed.
  38. O. V. Morozova, I. S. Vasil'eva, G. P. Shumakovich, E. A. Zaitseva and A. I. Yaropolov, Biochemistry, 2023, 88, s150–s175 CAS.
  39. L. Luo, W. Fan, J. Qin, S. Guo, H. Xiao and Z. Tang, Molecules, 2023, 28(14), 5538 CrossRef CAS PubMed.
  40. Y. Wang, S. Han, R. Li, B. Cui, X. Ma, X. Qi, Q. Hou, M. Lin, J. Bai and S. Li, Int. J. Biol. Macromol., 2019, 122, 628–635 CrossRef CAS PubMed.
  41. Z. Liao, R. Zeng, L. Hu, K. G. Maffucci and Y. Qu, Int. J. Biol. Macromol., 2019, 122, 1035–1045 CrossRef CAS PubMed.
  42. B. Wang, H. Zhang, L. Chen, Z. Mi, Y. Xu, G. Zhao, S. Liu, H. Lei, Z. Wang and J. Niu, Carbohydr. Polym., 2020, 246, 116620 CrossRef CAS PubMed.
  43. C. Zhang, F. Gao, S. Gan, Y. He, Z. Chen, X. Liu, C. Fu, Y. Qu and J. Zhang, Food Chem. Toxicol., 2019, 131, 110539 CrossRef CAS PubMed.
  44. M. Zhang, L. Sun, W. Zhao, X. Peng, F. Liu, Y. Wang, Y. Bi, H. Zhang and Y. Zhou, Molecules, 2014, 19, 9089–9100 CrossRef PubMed.
  45. C. Liu, K. Y. Dai, H. Y. Ji, X. Y. Jia and A. J. Liu, Int. J. Biol. Macromol., 2022, 205, 553–562 CrossRef CAS PubMed.
  46. L. Kong, L. Yu, T. Feng, X. Yin, T. Liu and L. Dong, Carbohydr. Polym., 2015, 125, 1–8 CrossRef CAS PubMed.
  47. Q. Yan, X. Long, P. Zhang, W. Lei, D. Sun and X. Ye, Carbohydr. Polym., 2022, 293, 119696 CrossRef CAS PubMed.
  48. Z. Y. Chen, S. H. Chen, C. H. Chen, P. Y. Chou, C. C. Yang and F. H. Lin, Polymers, 2020, 12(11), 2567 CrossRef CAS PubMed.
  49. G. L. Huang, Q. Yang and Z. B. Wang, Z. Naturforsch., C: J. Biosci., 2010, 65, 387–390 CrossRef CAS PubMed.
  50. G. A. Morris, G. G. Adams and S. E. Harding, Food Hydrocolloids, 2014, 42, 318–334 CrossRef CAS.
  51. A. Hussain, Int. J. Biol. Macromol., 2025, 309, 142802 CrossRef CAS PubMed.
  52. J. Xu, Z. Chen, P. Liu, Y. Wei, M. Zhang, X. Huang, L. Peng and X. Wei, Int. J. Biol. Macromol., 2021, 193, 2281–2289 CrossRef CAS PubMed.
  53. Q. Guo, B. Li, C. Bao, Y. Li, Y. Cao, C. Wang and W. Wu, Starch/Staerke, 2021, 73, 2000185 CrossRef CAS.
  54. L. Yue, W. Wang, Y. Wang, T. Du, W. Shen, H. Tang, Y. Wang and H. Yin, Int. J. Biol. Macromol., 2016, 89, 376–388 CrossRef CAS PubMed.
  55. L. Luo, Z. Zhou, J. Xue, Y. Wang, J. Zhang, X. Cai, Y. Liu and F. Yang, Exp. Ther. Med., 2018, 16, 1715–1722 Search PubMed.
  56. L. Luo, Y. Liu, X. Cai, Y. Wang, J. Xue, J. Zhang and F. Yang, Saudi. J. Gastroenterol, 2019, 25, 302–308 CrossRef PubMed.
  57. Y. Wang, W. Huang, J. Zhang, M. Yang, Q. Qi, K. Wang, A. Li and Z. Zhao, RSC Adv., 2016, 6, 89338–89346 RSC.
  58. H. Y. Hung and T. S. Wu, J. Food Drug Anal., 2016, 24, 221–238 CrossRef PubMed.
  59. L. Dong, X. X. Liu, S. X. Wu, Y. Mei, M. J. Liu, Y. X. Dong, J. Y. Huang, Y. J. Li, Y. Huang, Y. L. Wang and S. G. Liao, Biomed. Pharmacother., 2020, 130, 110537 CrossRef CAS PubMed.
  60. Y. Zhao, Q. Wang, S. Yan, J. Zhou, L. Huang, H. Zhu, F. Ye, Y. Zhang, L. Chen, L. Chen and T. Zheng, Front. Pharmacol., 2021, 12, 659215 CrossRef CAS PubMed.
  61. C. Zhang, Y. He, Z. Chen, J. Shi, Y. Qu and J. Zhang, J. Evidence-Based Complementary Altern. Med., 2019, 2019, 9212314 Search PubMed.
  62. Y. Wu and C. Y. Li, Cytotechnology, 2025, 77, 49 CrossRef CAS PubMed.
  63. Q. Li, K. Li, S.-S. Huang, H.-L. Zhang and Y.-P. Diao, Asian J. Chem., 2014, 26, 3574–3580 CrossRef CAS.
  64. J. Dai, S. Zhou and M. Liu, et al., Anhui Agric. Sci. Bull., 2015, 21, 3 Search PubMed.
  65. G. Li, Y. Zhang, E. Xie, X. Yang, H. Wang, X. Wang, W. Li, Z. Song, Q. Mu, W. Zhan, Q. Wu, J. Huang, Y. Chen, Y. Zhang, F. Wang and J. Min, Life Sci., 2019, 219, 11–19 CrossRef CAS PubMed.
  66. W. Liu and H. Mo, Chin. J. Immunol., 2021, 37, 941–945 Search PubMed.
  67. Y. Liu, C. Sun, G. Zhang, J. Wu, L. Huang, J. Qiao and Q. Guan, Int. J. Biol. Macromol., 2020, 142, 277–287 CrossRef CAS PubMed.
  68. S. Wang, J. Yu, Y. Liu, J. Yu, Y. Ma, L. Zhou, X. Liu, L. Liu, W. Li and X. Niu, J. Ethnopharmacol., 2024, 323, 117680 CrossRef CAS PubMed.
  69. T. Chen, X. Guo, Y. Huang, W. Hao, S. Deng, G. Xu, J. Bao, Q. Xiong and W. Yang, J. Biomater. Sci., Polym. Ed., 2023, 34, 1157–1170 CrossRef CAS PubMed.
  70. L. Wang, Y. Wu, J. Li, H. Qiao and L. Di, Int. J. Biol. Macromol., 2018, 120, 529–536 CrossRef CAS PubMed.
  71. N. Li, G. Zhang, X. Zhang, Y. Liu, Y. Kong, M. Wang and X. Ren, Int. J. Biol. Macromol., 2024, 261, 129667 CrossRef CAS PubMed.
  72. N. L. Morozowich, J. L. Nichol and H. R. Allcock, J. Polym. Sci., Part A: Polym. Chem., 2016, 54, 2984–2991 CrossRef CAS.
  73. X. Tian, X. Ji, R. Zhang, X. Long, J. Lin, Y. Zhang, L. Zhan, J. Luan, G. Zhao and X. Peng, J. Biomater. Appl., 2025, 39, 487–497 CrossRef CAS PubMed.
  74. A. Zennifer, S. Manivannan, S. Sethuraman, S. G. Kumbar and D. Sundaramurthi, Biomater. Adv., 2022, 134, 112576 CrossRef CAS PubMed.
  75. G. Ye, R. Jimo, Y. Lu, Z. Kong, Y. Axi, S. Huang, Y. Xiong, L. Zhang, G. Chen, Y. Xiao, P. Li, K. Gou and R. Zeng, Int. J. Biol. Macromol., 2024, 254, 127914 CrossRef CAS PubMed.
  76. Y. Zhang, X. Han, J. Zhao, M. Gan, Y. Chen, J. Zhang, Y. He, M. Wu and H. Liu, Biointerphases, 2024, 19(2), 021002 CrossRef CAS PubMed.
  77. W. Hu, Z. Wang, Y. Xiao, S. Zhang and J. Wang, Biomater. Sci., 2019, 7, 843–855 RSC.
  78. Y. Fan, R. Hong, X. Sun, Q. Luo, H. Wei, Y. Chen, Z. Zhang, X. Zhou and J. Wan, Int. J. Biol. Macromol., 2024, 258, 128815 CrossRef CAS PubMed.
  79. H. Li, P. Yang, P. Pageni and C. Tang, Macromol. Rapid Commun., 2017, 38(14), 1700109 CrossRef PubMed.
  80. C. Chen, P. Zhou, C. Huang, R. Zeng, L. Yang, Z. Han, Y. Qu and C. Zhang, Carbohydr. Polym., 2021, 273, 118557 CrossRef CAS.
  81. G. Zhong, P. Lei, P. Guo, Q. Yang, Y. Duan, J. Zhang, M. Qiu, K. Gou, C. Zhang, Y. Qu and R. Zeng, Small, 2024, 20, e2309568 CrossRef PubMed.
  82. L. Yang, Z. Han, C. Chen, Z. Li, S. Yu, Y. Qu and R. Zeng, Mater. Sci. Eng., C, 2020, 117, 111265 CrossRef CAS PubMed.
  83. S. Zhao, J. Zhang, M. Qiu, Y. Hou, X. Li, G. Zhong, K. Gou, J. Li, C. Zhang, Y. Qu and X. Wang, Int. J. Biol. Macromol., 2024, 254, 127761 CrossRef CAS PubMed.
  84. J. Wang, L. Zhang, L. Wang, J. Tang, W. Wang, Y. Xu, Z. Li, Z. Ding, X. Jiang, K. Xi, L. Chen and Y. Gu, Adv. Healthcare Mater., 2024, 13, e2303851 CrossRef.
  85. J. Shang, L. Duan, W. Zhang, Q. Zhuang, X. Ren and D. Gu, J. Biomater. Appl., 2024, 38, 943–956 CrossRef CAS PubMed.
  86. Z. Tang, N. Dan and Y. Chen, Int. J. Biol. Macromol., 2024, 259, 128389 CrossRef CAS PubMed.
  87. J. Lv, H. Ma, G. Ye, S. Jia, J. He and J. Wu, Mater. Des., 2023, 226, 111655 CrossRef CAS.
  88. N. S. Chandra, S. Gorantla, S. Priya and G. Singhvi, Carbohydr. Polym., 2022, 297, 120014 CrossRef CAS PubMed.
  89. P. Pahuja, S. Arora and P. Pawar, Expert Opin. Drug Delivery, 2012, 9, 837–861 CrossRef CAS PubMed.
  90. X. Wu, X. Yang, H. Jiang, Y. Xu, T. Liu, X. Zang and H. Gong, J. Ocul. Pharmacol. Ther., 2012, 28, 369–380 CrossRef CAS PubMed.
  91. X. G. Wu, M. Xin, H. Chen, L. N. Yang and H. R. Jiang, J. Pharm. Pharmacol., 2010, 62, 1152–1157 CrossRef CAS PubMed.
  92. S. H. Chen, P. Y. Chou, Z. Y. Chen, D. C. Chuang, S. T. Hsieh and F. H. Lin, Carbohydr. Polym., 2020, 250, 116981 CrossRef CAS PubMed.
  93. R. Yang, D. Wang, H. Li, Y. He, X. Zheng, M. Yuan and M. Yuan, Molecules, 2019, 24(11), 2104 CrossRef PubMed.
  94. L. F. Sun, M. M. Li, Y. Chen, W. J. Lu, Q. Zhang, N. Wang, W. Y. Fang, S. Gao, S. Q. Chen and R. F. Hu, Colloids Surf., B, 2023, 229, 113453 CrossRef CAS PubMed.
  95. H. Ma, Y. Axi, Y. Lu, C. Dai, S. Huang, Z. Kong, R. Jimo, H. Li, G. Chen, P. Li, L. Zhang, Y. Qu, X. Qin, R. Zeng and K. Gou, Int. J. Biol. Macromol., 2024, 265, 130780 CrossRef CAS PubMed.
  96. X. Zhang, Y. Wu, H. Gong, Y. Xiong, Y. Chen, L. Li, B. Zhi, S. Lv, T. Peng and H. Zhang, Small, 2024, e2400516,  DOI:10.1002/smll.202400516.
  97. X. Yue, S. Zhao, M. Qiu, J. Zhang, G. Zhong, C. Huang, X. Li, C. Zhang and Y. Qu, Carbohydr. Polym., 2023, 312, 120831 CrossRef CAS PubMed.
  98. H. Y. Zhang, K. T. Wang, Y. Zhang, Y. L. Cui and Q. Wang, Int. J. Biol. Macromol., 2023, 253, 127189 CrossRef CAS PubMed.
  99. Z. Ma, X. Yang, J. Ma, J. Lv, J. He, D. Jia, Y. Qu, G. Chen, H. Yan and R. Zeng, Colloids Surf., B, 2021, 208, 112066 CrossRef CAS PubMed.
  100. X. Yang, M. Jia, Z. Li, Z. Ma, J. Lv, D. Jia, D. He, R. Zeng, G. Luo and Y. Yu, Int. J. Biol. Macromol., 2022, 215, 550–559 CrossRef CAS PubMed.
  101. P. Zhou, S. Zhao, C. Huang, Y. Qu and C. Zhang, Int. J. Biol. Macromol., 2022, 205, 511–519 CrossRef CAS PubMed.
  102. L. Hu, Z. Liao, Q. Hu, K. G. Maffucci and Y. Qu, Int. J. Biol. Macromol., 2018, 117, 928–936 CrossRef CAS PubMed.
  103. T. Wu, X. Hou, J. Li, H. Ruan, L. Pei, T. Guo, Z. Wang, T. Ci, S. Ruan, Y. He, Z. He, N. Feng and Y. Zhang, ACS Nano, 2021, 15, 20087–20104 CrossRef CAS PubMed.

Footnote

† Jinxiang Fu and Yi Lu contributed equally to this work.
This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.